On January 24, 2023, Janet Linn moderated the CLE Panel, “Legal Attacks on Patent Thickets and Patent Settlements – Recent Efforts to Broaden a Drug Company's Potential Antitrust Liability” for the NYSBA’s Food, Drug & Cosmetic Law Section. The panel explored recent efforts to broaden the application of antitrust law to patents and patent litigation, and specifically pharmaceutical patents.

The panelists discussed the 7th Circuit Court of Appeals decision rejecting the accumulation of pharmaceutical and biologic patents as an antitrust violation. Additionally, the panel reviewed the “pay for delay” case law and state legislation to expand the reach of FTC v. Actavis, 570 U.S. 136 (2013) and apply multimillion dollar civil penalties to settlements of pharmaceutical patent litigation.